Igor V. Maev
Build. 6, 20 Delegatskaya St, 127473
Moscow, MOW, Russian Federation
Moscow, MOW, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 153 publications
Еxosomes: possibilities and prospects in the diagnosis and treatment of digestive diseases
Journal: Terapevticheskii arkhiv
Published: May 01, 2026
Effectiveness and Safety of First-Line Empirical Eradication Therapy with Rebamipide: Results from the European Registry on Helicobacter pylori Management (Hp-EuReg).
Journal: Antibiotics (Basel, Switzerland)
Published: April 15, 2026
Efficacy and Safety of Tegoprazan in Helicobacter pylori Eradication: An Umbrella Review of Meta-Analyses.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 10, 2026
Efficacy of ursodeoxycholic acid in metabolic dysfunction-associated steatotic liver disease: an umbrella review of meta-analyses on liver enzymes.
Journal: Frontiers in medicine
Published: December 19, 2025
Rebamipide as an Adjunctive Therapy for Gastrointestinal Diseases: An Umbrella Review.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 17, 2025
Global prevalence and risk of gastroesophageal reflux disease symptoms in pregnancy: a systematic review and meta-analysis.
Journal: BMC pregnancy and childbirth
Published: August 24, 2025
Tailored Therapy vs. Empirical Therapy for Helicobacter pylori Eradication: An Umbrella Review of Systematic Reviews and Meta-Analyses.
Journal: Journal of personalized medicine
Published: August 24, 2025
Cryptogenic steatotic liver disease: a clinical and instrumental study
Journal: Terapevticheskii arkhiv
Published: July 21, 2025
Current status and prospects of using potassium-competitive acid blockers in gastroenterology
Journal: Terapevticheskii arkhiv
Published: July 15, 2025
The Duration of Proton Pump Inhibitor Therapy and the Risk of Small Intestinal Bacterial Overgrowth: A Systematic Review and Meta-Analysis.
Journal: Journal of clinical medicine
Published: June 17, 2025
Prevalence and risk of small intestinal bacterial overgrowth in patients with rosacea: A systematic review and meta-analysis
Journal: Terapevticheskii arkhiv
Published: April 25, 2025
Study on the efficacy of combination therapy with rifaximin and Saccharomyces boulardii CNCM I-745 in patients with small intestinal bacterial overgrowth associated with long-term use of proton pump inhibitors
Journal: Terapevticheskii arkhiv
Published: April 23, 2025
Last Updated: 09/26/2026